Insider · CIK 0001529033

Vargas Thadd M

Reports to the SEC for 1 company · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001529033

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-06-13	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−21.8K sh	$9.59	−$209K	19,816
2017-06-13	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−19.8K sh	$9.60	−$190K	0
2017-06-13	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	+19.3K sh	$7.12	+$138K	19,320
2017-06-13	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	+45K sh	$6.08	+$274K	64,320
2017-06-13	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	+43K sh	$6.11	+$263K	107,320
2017-06-13	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	+53.5K sh	$6.77	+$362K	160,820
2017-06-13	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−161K sh	$9.53	−$1.53M	0
2017-06-13	Assertio Therapeutics, IncCommon StockM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	−19.3K sh	—	—	0
2017-06-13	Assertio Therapeutics, IncCommon StockM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	−45K sh	—	—	0
2017-06-13	Assertio Therapeutics, IncCommon StockM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	−43K sh	—	—	0
2017-06-13	Assertio Therapeutics, IncCommon StockM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	−53.5K sh	—	—	0
2017-05-11	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−50K sh	$12.03	−$601K	41,567
2017-04-02	Assertio Therapeutics, IncF Tax Payment	SVP, Business Development	FTax Payment	−940 sh	$12.55	−$11.8K	91,567
2017-02-08	Assertio Therapeutics, IncRestricted Stock UnitsA Award	SVP, Business Development	AAward	+10K sh	—	—	10,000
2017-02-08	Assertio Therapeutics, IncStock OptionsA Award	SVP, Business Development	AAward	+24K sh	—	—	24,000
2016-12-01	Assertio Therapeutics, IncF Tax Payment	SVP, Business Development	FTax Payment	−10.1K sh	$18.55	−$187K	90,007
2016-09-21	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−11.3K sh	$25.00	−$281K	73,086
2016-08-10	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−26.3K sh	$20.92	−$550K	84,336
2016-05-23	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−15K sh	$20.00	−$300K	109,297
2016-05-10	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−15K sh	$17.64	−$265K	124,297
2016-04-02	Assertio Therapeutics, IncF Tax Payment	SVP, Business Development	FTax Payment	−940 sh	$14.38	−$13.5K	139,297
2016-03-11	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−23K sh	$16.00	−$368K	137,737
2016-03-02	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−10K sh	$15.18	−$152K	160,737
2016-02-11	Assertio Therapeutics, IncRestricted Stock UnitA Award	SVP, Business Development	AAward	+25K sh	—	—	25,000
2016-02-11	Assertio Therapeutics, IncStock OptionA Award	SVP, Business Development	AAward	+60K sh	—	—	60,000
2016-01-11	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	+18.2K sh	$7.12	+$129K	170,737
2016-01-11	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	−18.2K sh	—	—	0
2015-12-01	Assertio Therapeutics, IncF Tax Payment	SVP, Business Development	FTax Payment	−14K sh	$19.00	−$265K	152,557
2015-06-12	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−5,000 sh	$20.70	−$104K	138,153
2015-05-12	Assertio Therapeutics, IncRestricted Stock UnitsA Award	SVP, Business Development	AAward	+5,000 sh	—	—	5,000
2015-04-08	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	+52.5K sh	$6.29	+$330K	140,943
2015-04-08	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	+1,875 sh	$3.60	+$6,750	142,818
2015-04-08	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	+335 sh	$3.09	+$1,035.15	143,153
2015-04-08	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	−52.5K sh	—	—	0
2015-04-08	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	−1,875 sh	—	—	0
2015-04-08	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	−335 sh	—	—	0
2015-02-04	Assertio Therapeutics, IncRestricted Stock UnitA Award	SVP, Business Development	AAward	+20.5K sh	—	—	20,500
2015-02-04	Assertio Therapeutics, IncStock OptionA Award	SVP, Business Development	AAward	+50K sh	—	—	50,000
2015-01-20	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	+19K sh	$5.03	+$95.6K	88,443
2015-01-20	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	−19K sh	—	—	0
2014-12-02	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−8,247 sh	$15.85	−$131K	69,443
2014-03-14	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	+10K sh	$5.08	+$50.8K	77,948
2014-03-14	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−63.9K sh	$14.69	−$938K	14,079
2014-03-14	Assertio Therapeutics, IncStock OptionsM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	−10K sh	—	—	0
2014-02-18	Assertio Therapeutics, IncRestricted Stock UnitA Award	SVP, Business Development	AAward	+33K sh	—	—	33,000
2014-02-18	Assertio Therapeutics, IncStock OptionA Award	SVP, Business Development	AAward	+80K sh	—	—	80,000
2013-12-02	Assertio Therapeutics, IncS Sale	SVP, Business Development	SSale	−5,296 sh	$8.40	−$44.5K	61,698
2013-03-04	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	+8,750 sh	$1.83	+$16K	47,619
2013-03-04	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	SVP, Business Development	MExercise/Conversion	−8,750 sh	—	—	0
2013-02-07	Assertio Therapeutics, IncRestricted Stock UnitA Award	SVP, Business Development	AAward	+28.5K sh	—	—	28,500

Recent filings

Accepted (ET)
Jun 154
DEPOMED INC0001179110-17-009109
SEC(opens sec.gov)
May 154
DEPOMED INC0001179110-17-007220
SEC(opens sec.gov)
Apr 44
DEPOMED INC0001179110-17-005718
SEC(opens sec.gov)
Feb 104
DEPOMED INC0001179110-17-002200
SEC(opens sec.gov)
Dec 64
DEPOMED INC0001179110-16-032492
SEC(opens sec.gov)
Sep 224
DEPOMED INC0001179110-16-029940
SEC(opens sec.gov)
Aug 114
DEPOMED INC0001179110-16-028585
SEC(opens sec.gov)
May 254
DEPOMED INC0001179110-16-025503
SEC(opens sec.gov)
May 104
DEPOMED INC0001179110-16-024258
SEC(opens sec.gov)

Companies

Assertio Therapeutics, IncSVP, Business Development

Address

1360 O'BRIEN DRIVE

MENLO PARK, CA, 94025